Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression
2022 · Signal Transduction and Targeted Therapy · 35 citations
https://doi.org/10.1038/s41392-022-00952-w
K
Kaicheng Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
328
Citations
8
h-index
6
i10-index
Kaicheng Zhou is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Luminescence and Fluorescent Materials & RNA modifications and cancer & MicroRNA in disease regulation. The author has an h-index of 8, co-authored 33 publications.
ORCID: 0009-0008-4731-1005Papers by this author
worksCMAUP database update 2024: extended functional and association information of useful plants for biomedical research
2023 · Nucleic Acids Research · 21 citations
https://doi.org/10.1093/nar/gkad921
Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy
2025 · Signal Transduction and Targeted Therapy · 3 citations
https://doi.org/10.1038/s41392-025-02512-4
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development
2025 · Journal of Experimental & Clinical Cancer Research · 2 citations
https://doi.org/10.1186/s13046-025-03413-8
TargetPair: A Single Cell-omics Resource of Clinical Trials-derived Therapeutical Target Combinations for Cancer Therapy
2025 · Journal of Molecular Biology · 1 citations
https://doi.org/10.1016/j.jmb.2025.169399
Multicolor fluorescent adjustable hydrogel with high toughness, used for information encryption and alkaline stimulation response
2025 · Optical Materials · 0 citations
https://doi.org/10.1016/j.optmat.2025.117386
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat